Yes. The therapeutic products directorate did in fact ban the products through the notice that was issued on March 27, 2009. The problem was that they then did not enforce the regulation for reasons that are not particularly well known to me. But what we've been told is they said, “Well, people aren't smoking these and then dying right away. We're busy with other things. We're busy with other regulatory approaches.” So the way they look at it is to say, “Well, we'll call that a risk management approach. There are other products that are creating more immediate risks than these ones, so we're going to leave those ones alone.”
I don't think that's a very good tradeoff, immediate risks versus potential risks in the future. I think we need sensible control of both.